Free Trial

Oracle (ORCL) Financials

Oracle logo
$236.17 +3.01 (+1.29%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$236.91 +0.74 (+0.31%)
As of 08/22/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Oracle

Annual Income Statements for Oracle

This table shows Oracle's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 5/31/2015 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025
Net Income / (Loss) Attributable to Common Shareholders
9,938 8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443
Consolidated Net Income / (Loss)
9,938 8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443
Net Income / (Loss) Continuing Operations
9,938 8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443
Total Pre-Tax Income
12,834 11,442 11,680 12,424 12,268 12,063 12,999 7,649 9,126 11,741 14,160
Total Operating Income
13,871 12,604 12,913 13,264 13,535 13,896 15,213 10,926 13,093 15,353 17,678
Total Gross Profit
30,694 29,568 30,340 31,323 34,364 33,946 35,154 36,255 41,151 42,643 45,048
Total Revenue
38,226 37,047 37,792 39,383 39,506 39,068 40,479 42,440 49,954 52,961 57,399
Operating Revenue
38,226 37,047 37,792 39,383 39,506 39,068 40,479 42,440 49,954 52,961 57,399
Total Cost of Revenue
7,532 7,479 7,452 8,060 5,142 5,122 5,325 6,185 8,803 10,318 12,351
Operating Cost of Revenue
7,532 7,479 7,452 8,060 5,142 5,122 5,325 6,185 8,803 10,318 12,351
Total Operating Expenses
16,823 16,964 17,427 18,059 20,829 20,050 19,941 25,329 28,058 27,290 27,370
Selling, General & Admin Expense
1,077 1,155 1,172 1,282 1,265 1,181 1,254 1,317 1,579 1,548 1,602
Marketing Expense
7,655 7,884 8,085 8,433 8,509 8,094 7,682 8,047 8,833 8,274 8,651
Research & Development Expense
5,524 5,787 6,153 6,084 6,026 6,067 6,527 7,219 8,623 8,915 9,860
Amortization Expense
2,149 1,638 1,451 1,620 1,689 1,586 1,379 1,150 3,582 3,010 2,307
Other Operating Expenses / (Income)
- - - - 2,853 2,816 2,530 2,692 4,761 4,825 4,576
Restructuring Charge
418 500 566 640 487 306 569 4,904 680 718 374
Total Other Income / (Expense), net
-1,037 -1,162 -1,233 -840 -1,267 -1,833 -2,214 -3,277 -3,967 -3,612 -3,518
Interest Expense
1,143 1,467 1,798 2,025 2,082 1,995 2,496 2,755 3,505 3,514 3,578
Other Income / (Expense), net
106 305 565 1,185 815 162 282 -522 -462 -98 60
Income Tax Expense
2,896 2,541 2,228 8,837 1,185 1,928 -747 932 623 1,274 1,717
Basic Earnings per Share
$2.26 $2.11 $2.30 $0.87 $3.05 $3.16 $4.67 $2.49 $3.15 $3.82 $4.46
Weighted Average Basic Shares Outstanding
4.40B 4.22B 4.12B 4.12B 3.63B 3.21B 2.95B 2.70B 2.70B 2.74B 2.79B
Diluted Earnings per Share
$2.21 $2.07 $2.24 $0.85 $2.97 $3.08 $4.55 $2.41 $3.07 $3.71 $4.34
Weighted Average Diluted Shares Outstanding
4.50B 4.31B 4.22B 4.24B 3.73B 3.29B 3.02B 2.79B 2.77B 2.82B 2.87B
Weighted Average Basic & Diluted Shares Outstanding
4.34B 4.12B 4.11B 4.12B 3.63B 3.07B 2.79B 2.66B 2.71B 2.76B 2.81B
Cash Dividends to Common per Share
$0.51 $0.60 $0.64 $0.76 $0.81 $0.96 $1.04 $1.28 $1.36 $1.60 $1.70

Quarterly Income Statements for Oracle

This table shows Oracle's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 11/30/2022 2/28/2023 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,741 1,896 3,318 2,420 2,503 2,401 3,143 2,929 3,151 2,936 3,427
Consolidated Net Income / (Loss)
1,741 1,896 3,318 2,420 2,503 2,401 3,143 2,929 3,151 2,936 3,427
Net Income / (Loss) Continuing Operations
1,741 1,896 3,318 2,420 2,503 2,401 3,143 2,929 3,151 2,936 3,427
Total Pre-Tax Income
2,144 2,218 3,108 2,375 2,720 2,865 3,781 3,169 3,390 3,448 4,153
Total Operating Income
3,071 3,260 4,139 3,296 3,622 3,750 4,685 3,991 4,220 4,358 5,109
Total Gross Profit
10,098 10,174 11,418 10,055 10,454 10,611 11,523 10,548 11,141 11,051 12,308
Total Revenue
12,275 12,398 13,836 12,453 12,941 13,280 14,287 13,307 14,059 14,130 15,903
Operating Revenue
12,275 12,398 13,836 12,453 12,941 13,280 14,287 13,307 14,059 14,130 15,903
Total Cost of Revenue
2,177 2,224 2,418 2,398 2,487 2,669 2,764 2,759 2,918 3,079 3,595
Operating Cost of Revenue
2,177 2,224 2,418 2,398 2,487 2,669 2,764 2,759 2,918 3,079 3,595
Total Operating Expenses
7,027 6,914 7,279 6,759 6,832 6,861 6,838 6,557 6,921 6,693 7,199
Selling, General & Admin Expense
366 402 400 393 375 377 403 358 387 390 467
Marketing Expense
2,216 2,150 2,290 2,026 2,093 2,042 2,113 2,036 2,190 2,119 2,306
Research & Development Expense
2,158 2,146 2,226 2,216 2,226 2,248 2,225 2,306 2,471 2,429 2,654
Amortization Expense
907 886 870 763 755 749 743 624 591 548 544
Other Operating Expenses / (Income)
1,181 1,215 1,312 1,212 1,253 1,200 1,160 1,147 1,167 1,116 1,146
Restructuring Charge
199 115 181 149 130 245 194 86 115 91 82
Total Other Income / (Expense), net
-927 -1,042 -1,031 -921 -902 -885 -904 -822 -830 -910 -956
Interest Expense
856 908 954 872 888 876 878 842 866 892 978
Other Income / (Expense), net
-71 -134 -77 -49 -14 -9.00 -26 20 36 -18 22
Income Tax Expense
403 322 -210 -45 217 464 638 240 239 512 726
Basic Earnings per Share
$0.65 $0.70 $1.22 $0.89 $0.91 $0.87 $1.15 $1.06 $1.13 $1.05 $1.22
Weighted Average Basic Shares Outstanding
2.70B 2.70B 2.70B 2.73B 2.75B 2.75B 2.74B 2.76B 2.79B 2.80B 2.79B
Diluted Earnings per Share
$0.63 $0.68 $1.20 $0.86 $0.89 $0.85 $1.11 $1.03 $1.10 $1.02 $1.19
Weighted Average Diluted Shares Outstanding
2.75B 2.78B 2.77B 2.82B 2.82B 2.82B 2.82B 2.85B 2.87B 2.87B 2.87B
Weighted Average Basic & Diluted Shares Outstanding
2.70B 2.70B 2.71B 2.74B 2.75B 2.75B 2.76B 2.77B 2.80B 2.80B 2.81B

Annual Cash Flow Statements for Oracle

This table details how cash moves in and out of Oracle's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 5/31/2015 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025
Net Change in Cash & Equivalents
3,947 -1,564 1,632 -164 -1,106 16,725 -7,141 -8,715 -11,618 689 332
Net Cash From Operating Activities
14,580 13,685 14,126 15,386 14,551 13,139 15,887 9,539 17,165 18,673 20,821
Net Cash From Continuing Operating Activities
14,580 13,685 14,126 15,386 14,551 13,139 15,887 9,539 17,165 18,673 20,821
Net Income / (Loss) Continuing Operations
9,938 8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443
Consolidated Net Income / (Loss)
9,938 8,901 9,452 3,587 11,083 10,135 13,746 6,717 8,503 10,467 12,443
Depreciation Expense
712 871 1,000 1,165 1,230 1,382 1,537 1,972 2,526 3,129 3,867
Amortization Expense
2,149 1,638 1,451 1,620 1,689 1,586 1,379 1,150 3,582 3,010 2,307
Non-Cash Adjustments To Reconcile Net Income
1,316 1,310 1,605 1,780 2,000 1,829 1,798 2,833 4,208 4,694 5,341
Changes in Operating Assets and Liabilities, net
465 965 618 7,270 -1,451 -1,793 -2,573 -3,133 -1,654 -2,627 -3,137
Net Cash From Investing Activities
-19,047 -5,154 -21,494 -5,625 26,557 9,843 -13,098 11,220 -36,484 -7,360 -21,711
Net Cash From Continuing Investing Activities
-19,047 -5,154 -21,494 -5,625 26,557 9,843 -13,098 11,220 -36,484 -7,360 -21,711
Purchase of Property, Plant & Equipment
-1,391 -1,189 -2,021 -1,736 -1,660 -1,564 -2,135 -4,511 -8,695 -6,866 -21,215
Acquisitions
-6,239 -650 -11,221 -1,724 -363 -124 -41 -148 -27,721 -63 0.00
Purchase of Investments
-31,421 -24,562 -25,867 -25,282 -1,400 -5,731 -37,982 -10,272 -1,181 -1,003 -1,272
Sale and/or Maturity of Investments
20,004 21,247 17,615 23,117 29,980 17,262 27,060 26,151 1,113 572 776
Net Cash From Financing Activities
9,606 -9,980 9,086 -9,982 -42,056 -6,132 -10,378 -29,126 7,910 -10,554 1,098
Net Cash From Continuing Financing Activities
9,606 -9,980 9,086 -9,982 -42,056 -6,132 -10,378 -29,126 7,910 -10,554 1,098
Repayment of Debt
-1,500 -2,000 -4,352 -9,834 -4,636 -4,633 -2,435 -8,810 -21,105 -3,496 -14,749
Repurchase of Common Equity
-8,087 -10,440 -3,561 -11,347 -36,140 -19,240 -20,934 -16,248 -1,300 -1,202 -600
Payment of Dividends
-2,451 -2,626 -2,631 -3,140 -2,932 -3,070 -3,063 -3,457 -3,668 -4,391 -4,743
Issuance of Debt
19,842 3,750 17,732 12,443 0.00 19,888 14,934 0.00 33,994 -167 21,437
Issuance of Common Equity
1,816 1,425 2,181 2,402 2,155 1,588 1,786 482 1,192 742 653
Other Financing Activities, net
-14 -89 -283 -506 -503 -665 -666 -1,093 -1,203 -2,040 -900
Effect of Exchange Rate Changes
-1,192 -115 - - - - 448 -348 -209 -70 124
Cash Interest Paid
1,022 1,616 1,612 1,910 2,059 1,972 2,408 2,735 3,250 3,655 3,374
Cash Income Taxes Paid
3,055 2,331 1,983 1,562 2,901 3,218 3,189 2,567 3,009 3,560 4,020

Quarterly Cash Flow Statements for Oracle

This table details how cash moves in and out of Oracle's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 11/30/2022 2/28/2023 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025
Net Change in Cash & Equivalents
-3,635 1,406 1,546 1,848 -3,369 1,237 973 162 325 6,465 -6,620
Net Cash From Operating Activities
849 4,275 5,647 6,974 143 5,475 6,081 7,427 1,304 5,933 6,157
Net Cash From Continuing Operating Activities
849 4,275 5,647 6,974 143 5,475 6,081 7,427 1,304 5,933 6,157
Net Income / (Loss) Continuing Operations
1,741 1,895 3,319 2,420 2,503 2,400 3,144 2,929 3,151 2,936 3,427
Consolidated Net Income / (Loss)
1,741 1,895 3,319 2,420 2,503 2,400 3,144 2,929 3,151 2,936 3,427
Depreciation Expense
591 672 716 712 798 808 811 804 908 1,003 1,152
Amortization Expense
907 886 870 763 755 749 743 624 591 548 544
Non-Cash Adjustments To Reconcile Net Income
1,042 1,122 1,138 1,018 1,191 1,349 1,136 986 1,488 1,322 1,545
Changes in Operating Assets and Liabilities, net
-3,432 -300 -396 2,061 -5,104 169 247 2,084 -4,834 124 -511
Net Cash From Investing Activities
-2,658 -2,778 -1,612 -1,562 -1,249 -1,783 -2,766 -2,765 -3,788 -5,976 -9,182
Net Cash From Continuing Investing Activities
-2,658 -2,778 -1,612 -1,562 -1,249 -1,783 -2,766 -2,765 -3,788 -5,976 -9,182
Purchase of Property, Plant & Equipment
-2,435 -2,628 -1,913 -1,314 -1,080 -1,674 -2,798 -2,303 -3,970 -5,862 -9,080
Purchase of Investments
-546 -318 -260 -333 -182 -159 -329 -477 -159 -202 -434
Sale and/or Maturity of Investments
324 90 561 85 72 50 365 15 341 88 332
Net Cash From Financing Activities
-1,855 -105 -2,440 -3,528 -2,289 -2,463 -2,274 -4,585 2,938 6,559 -3,814
Net Cash From Continuing Financing Activities
-1,855 -105 -2,440 -3,528 -2,289 -2,463 -2,274 -4,585 2,938 6,559 -3,814
Repayment of Debt
-10,738 -2,379 -1,478 -1,535 -1,934 -810 -966 -8,287 -1,689 -94 -4,679
Repurchase of Common Equity
-448 -150 -150 -150 -450 -450 -152 -150 -150 -150 -150
Payment of Dividends
-863 -863 -1,082 -1,091 -1,099 -1,099 -1,102 -1,103 -1,118 -1,119 -1,403
Issuance of Debt
10,114 3,334 - 0.00 1,749 - -167 5,627 5,814 7,711 2,285
Issuance of Common Equity
146 98 433 308 118 28 288 179 128 213 133
Effect of Exchange Rate Changes
29 14 - -36 26 8.00 -68 85 -129 -51 219

Annual Balance Sheets for Oracle

This table presents Oracle's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 5/31/2015 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025
Total Assets
110,903 112,180 134,991 137,851 108,709 115,438 131,107 109,297 134,384 140,976 168,361
Total Current Assets
62,520 64,313 74,515 76,159 46,386 52,140 55,567 31,633 21,004 22,554 24,579
Cash & Equivalents
21,716 20,152 21,784 21,620 20,514 37,239 30,098 21,383 9,765 10,454 10,786
Short-Term Investments
32,652 35,973 44,294 45,641 17,313 5,818 16,456 519 422 207 417
Accounts Receivable
5,618 5,385 5,300 5,136 5,134 5,551 5,409 5,953 6,915 7,874 8,558
Prepaid Expenses
- 2,591 3,137 3,762 3,425 3,532 3,604 3,778 3,902 4,019 4,818
Plant, Property, & Equipment, net
3,686 4,000 5,315 5,897 6,252 6,244 7,049 9,716 17,069 21,536 43,522
Total Noncurrent Assets
44,697 43,867 55,161 55,795 56,071 57,054 68,491 67,948 96,311 96,886 100,260
Goodwill
34,087 34,590 43,045 43,755 43,779 43,769 43,935 43,811 62,261 62,230 62,207
Intangible Assets
6,406 4,943 7,679 6,670 5,279 3,738 2,430 1,440 9,837 6,890 4,587
Noncurrent Deferred & Refundable Income Taxes
1,458 1,291 1,143 1,395 2,696 3,252 13,636 12,782 12,226 12,273 11,877
Other Noncurrent Operating Assets
2,746 3,043 3,294 3,975 4,317 6,295 8,490 9,915 11,987 15,493 21,589
Total Liabilities & Shareholders' Equity
110,903 112,180 134,991 137,851 108,709 115,438 131,107 109,297 134,384 140,976 168,361
Total Liabilities
61,805 64,390 80,745 90,978 86,346 102,721 125,155 115,065 132,828 131,737 147,392
Total Current Liabilities
15,206 17,208 24,178 19,124 18,630 17,200 24,164 19,511 23,090 31,544 32,643
Short-Term Debt
1,999 3,750 9,797 4,491 4,494 2,371 8,250 3,749 4,061 10,605 7,271
Accounts Payable
806 504 599 529 580 637 745 1,317 1,204 2,357 5,113
Current Deferred Revenue
7,245 7,655 8,233 8,341 8,374 8,002 8,775 8,357 8,970 9,313 9,387
Current Employee Benefit Liabilities
1,839 1,966 1,966 1,806 1,628 1,453 2,017 1,944 2,053 1,916 2,243
Other Current Liabilities
3,317 3,333 3,583 3,957 3,554 4,737 4,377 4,144 6,802 7,353 8,629
Total Noncurrent Liabilities
46,599 47,182 56,567 71,854 67,716 85,521 100,991 95,554 109,738 100,193 114,749
Long-Term Debt
39,959 40,105 48,112 56,128 51,673 69,226 75,995 72,110 86,420 76,264 85,297
Noncurrent Deferred Revenue
4,386 4,908 5,681 13,429 13,295 12,463 12,345 12,210 11,077 10,817 10,269
Other Noncurrent Operating Liabilities
2,254 2,169 2,774 2,297 2,748 3,791 4,787 5,203 6,469 13,112 19,183
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
49,098 47,790 54,246 46,873 22,363 12,717 5,952 -5,768 1,556 9,239 20,969
Total Preferred & Common Equity
48,663 47,289 53,860 46,372 21,785 12,074 5,238 -6,220 1,073 8,704 20,451
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
48,663 47,289 53,860 46,372 21,785 12,074 5,238 -6,220 1,073 8,704 20,451
Common Stock
23,156 24,217 27,065 28,950 26,909 26,486 26,533 26,808 30,215 32,764 37,107
Retained Earnings
26,503 23,888 27,598 19,111 -3,496 -12,696 -20,120 -31,336 -27,620 -22,628 -15,481
Accumulated Other Comprehensive Income / (Loss)
-996 -816 -803 -1,689 -1,628 -1,716 -1,175 -1,692 -1,522 -1,432 -1,175
Noncontrolling Interest
435 501 386 501 578 643 714 452 483 535 518

Quarterly Balance Sheets for Oracle

This table presents Oracle's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 8/31/2022 11/30/2022 2/28/2023 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025
Total Assets
130,309 128,469 131,620 134,384 136,662 134,324 137,082 140,976 144,214 148,483 161,378
Total Current Assets
21,004 17,561 18,696 21,004 22,166 19,289 21,063 22,554 23,072 23,503 30,116
Cash & Equivalents
10,448 6,813 8,219 9,765 11,613 8,244 9,481 10,454 10,616 10,941 17,406
Short-Term Investments
772 537 550 422 470 446 423 207 295 370 417
Accounts Receivable
5,937 6,197 6,213 6,915 6,519 6,804 7,297 7,874 8,021 8,177 8,051
Prepaid Expenses
3,847 4,014 3,714 3,902 3,564 3,795 3,862 4,019 4,140 4,015 4,242
Plant, Property, & Equipment, net
12,280 14,351 16,345 17,069 17,644 18,009 19,117 21,536 23,094 26,432 31,970
Total Noncurrent Assets
97,025 96,557 96,579 96,311 96,852 97,026 96,902 96,886 98,048 98,548 99,292
Goodwill
61,629 61,513 61,499 62,261 62,206 62,231 62,222 62,230 62,249 62,204 62,171
Intangible Assets
12,499 11,593 10,707 9,837 9,074 8,378 7,629 6,890 6,270 5,679 5,131
Noncurrent Deferred & Refundable Income Taxes
12,065 12,091 12,153 12,226 12,243 12,758 12,688 12,273 12,219 11,984 11,799
Other Noncurrent Operating Assets
10,832 11,360 12,220 11,987 13,329 13,659 14,363 15,493 17,310 18,681 20,191
Total Liabilities & Shareholders' Equity
130,309 128,469 131,620 134,384 136,662 134,324 137,082 140,976 144,214 148,483 161,378
Total Liabilities
135,758 132,245 133,532 132,828 133,821 129,946 130,900 131,737 132,945 134,247 144,117
Total Current Liabilities
34,819 27,106 22,880 23,090 25,357 24,407 24,885 31,544 32,045 29,052 29,623
Short-Term Debt
16,097 9,746 5,415 4,061 4,499 6,321 5,510 10,605 9,201 8,162 8,167
Accounts Payable
1,461 1,647 1,610 1,204 1,034 1,107 1,658 2,357 2,207 2,679 2,423
Current Deferred Revenue
10,473 8,705 8,598 8,970 11,120 8,878 8,931 9,313 11,455 9,430 9,019
Current Employee Benefit Liabilities
1,958 1,780 1,736 2,053 1,818 1,706 1,796 1,916 1,772 1,653 1,839
Other Current Liabilities
4,830 5,228 5,521 6,802 6,886 6,395 6,990 7,353 7,410 7,128 8,175
Total Noncurrent Liabilities
100,939 105,139 110,652 109,738 108,464 105,539 106,015 100,193 100,900 105,195 114,494
Long-Term Debt
75,480 81,173 86,396 86,420 84,442 82,468 82,470 76,264 75,314 80,462 88,109
Noncurrent Deferred Revenue
12,128 11,128 11,335 11,077 11,201 10,046 10,451 10,817 11,038 9,553 9,813
Noncurrent Deferred & Payable Income Tax Liabilities
7,693 7,165 6,814 5,772 5,281 5,244 4,483 3,692 3,442 2,864 2,208
Other Noncurrent Operating Liabilities
5,638 5,673 6,107 6,469 7,540 7,781 8,611 9,420 11,106 12,316 14,364
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-5,449 -3,776 -1,912 1,556 2,841 4,378 6,182 9,239 11,269 14,236 17,261
Total Preferred & Common Equity
-5,875 -4,246 -2,421 1,073 2,370 3,866 5,623 8,704 10,816 13,746 16,730
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-5,875 -4,246 -2,421 1,073 2,370 3,866 5,623 8,704 10,816 13,746 16,730
Common Stock
27,224 28,148 28,994 30,215 30,295 30,724 31,622 32,764 33,083 34,310 35,691
Retained Earnings
-31,134 -30,617 -29,721 -27,620 -26,428 -25,431 -24,533 -22,628 -20,939 -19,045 -17,368
Accumulated Other Comprehensive Income / (Loss)
-1,965 -1,777 -1,694 -1,522 -1,497 -1,427 -1,466 -1,432 -1,328 -1,519 -1,593
Noncontrolling Interest
426 470 509 483 471 512 559 535 453 490 531

Annual Metrics And Ratios for Oracle

This table displays calculated financial ratios and metrics derived from Oracle's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 5/31/2015 5/31/2016 5/31/2017 5/31/2018 5/31/2019 5/31/2020 5/31/2021 5/31/2022 5/31/2023 5/31/2024 5/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.13% -3.08% 2.01% 4.21% 0.31% -1.11% 3.61% 4.84% 17.71% 6.02% 8.38%
EBITDA Growth
-3.93% -8.43% 3.31% 8.19% 0.20% -1.41% 8.13% -26.53% 38.54% 14.17% 11.77%
EBIT Growth
-4.39% -7.64% 4.41% 7.20% -0.69% -2.03% 10.22% -32.86% 21.41% 20.77% 16.28%
NOPAT Growth
-8.96% -8.71% 6.58% -63.35% 219.30% -4.52% 37.79% -40.36% 27.14% 12.20% 13.50%
Net Income Growth
-9.28% -10.43% 6.19% -62.05% 208.98% -8.55% 35.63% -51.13% 26.59% 23.10% 18.88%
EPS Growth
-7.14% -6.33% 8.21% -62.05% 249.41% 3.70% 47.73% -47.03% 27.39% 20.85% 16.98%
Operating Cash Flow Growth
0.96% -6.14% 3.22% 8.92% -5.43% -9.70% 20.91% -39.96% 79.95% 8.79% 11.50%
Free Cash Flow Firm Growth
-35.43% 61.89% -100.98% 9,125.76% 21.50% -5.40% 23.20% -63.15% -525.09% 147.01% -113.41%
Invested Capital Growth
12.11% -3.18% 29.72% -12.69% 1.17% 1.36% 5.78% 10.42% 69.85% 4.39% 19.76%
Revenue Q/Q Growth
-1.59% -0.30% 0.97% 0.14% 0.31% -1.75% 1.98% 1.46% 4.16% 0.86% 2.90%
EBITDA Q/Q Growth
-4.60% -0.41% 2.89% 0.19% -0.07% -0.86% 3.42% -3.19% 2.68% 2.71% 2.64%
EBIT Q/Q Growth
-5.44% 0.55% 2.36% 0.35% -0.44% -0.82% 3.87% -4.80% -2.06% 4.07% 2.73%
NOPAT Q/Q Growth
-7.97% 0.23% 6.79% -2.70% 5.47% -4.11% 4.95% -5.33% 4.41% -3.86% 2.10%
Net Income Q/Q Growth
-8.21% 0.66% 5.99% -1.99% 4.37% -5.80% 7.14% -11.16% 1.55% -1.64% 2.34%
EPS Q/Q Growth
-7.53% 2.48% 6.67% 1.19% 8.00% -1.91% 9.11% -6.95% 0.99% -2.37% 1.88%
Operating Cash Flow Q/Q Growth
3.90% -6.92% 5.00% 1.28% -1.61% -5.79% 8.38% -8.24% 10.72% 2.38% 0.37%
Free Cash Flow Firm Q/Q Growth
-1.24% -1.32% 39.74% -12.37% 20.46% -6.11% 5.76% -21.04% 5.17% -9.17% -135.98%
Invested Capital Q/Q Growth
-0.88% -0.43% 0.96% 4.41% 0.83% 1.37% 1.33% 2.94% 0.89% 1.41% 6.92%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
80.30% 79.81% 80.28% 79.53% 86.98% 86.89% 86.85% 85.43% 82.38% 80.52% 78.48%
EBITDA Margin
44.05% 41.62% 42.15% 43.76% 43.71% 43.58% 45.48% 31.87% 37.51% 40.40% 41.66%
Operating Margin
36.29% 34.02% 34.17% 33.68% 34.26% 35.57% 37.58% 25.74% 26.21% 28.99% 30.80%
EBIT Margin
36.56% 34.84% 35.66% 36.69% 36.32% 35.98% 38.28% 24.51% 25.29% 28.80% 30.90%
Profit (Net Income) Margin
26.00% 24.03% 25.01% 9.11% 28.05% 25.94% 33.96% 15.83% 17.02% 19.76% 21.68%
Tax Burden Percent
77.43% 77.79% 80.92% 28.87% 90.34% 84.02% 105.75% 87.82% 93.17% 89.15% 87.87%
Interest Burden Percent
91.82% 88.64% 86.66% 85.99% 85.49% 85.81% 83.89% 73.52% 72.25% 76.96% 79.83%
Effective Tax Rate
22.57% 22.21% 19.08% 71.13% 9.66% 15.98% -5.75% 12.18% 6.83% 10.85% 12.13%
Return on Invested Capital (ROIC)
30.95% 27.16% 25.61% 8.87% 30.22% 28.49% 37.90% 20.90% 18.76% 16.36% 16.55%
ROIC Less NNEP Spread (ROIC-NNEP)
36.87% 34.48% 35.38% 12.15% 10.65% 21.92% 30.83% 14.62% 13.26% 12.25% 12.62%
Return on Net Nonoperating Assets (RNNOA)
-10.36% -8.78% -7.09% -1.78% 1.80% 29.29% 109.36% 7,280.19% -422.51% 177.56% 65.84%
Return on Equity (ROE)
20.59% 18.37% 18.53% 7.09% 32.02% 57.78% 147.26% 7,301.09% -403.75% 193.92% 82.38%
Cash Return on Invested Capital (CROIC)
19.53% 30.39% -0.26% 22.42% 29.05% 27.14% 32.28% 11.00% -33.01% 12.06% -1.44%
Operating Return on Assets (OROA)
13.90% 11.57% 10.91% 10.59% 11.64% 12.54% 12.57% 8.66% 10.37% 11.08% 11.47%
Return on Assets (ROA)
9.88% 7.98% 7.65% 2.63% 8.99% 9.04% 11.15% 5.59% 6.98% 7.60% 8.04%
Return on Common Equity (ROCE)
20.37% 18.20% 18.37% 7.03% 31.52% 55.77% 136.56% -38,965.58% -493.38% 175.64% 79.51%
Return on Equity Simple (ROE_SIMPLE)
20.42% 18.82% 17.55% 7.74% 50.87% 83.94% 262.43% -107.99% 792.45% 120.26% 60.84%
Net Operating Profit after Tax (NOPAT)
10,741 9,805 10,450 3,830 12,228 11,675 16,087 9,595 12,199 13,687 15,534
NOPAT Margin
28.10% 26.47% 27.65% 9.72% 30.95% 29.88% 39.74% 22.61% 24.42% 25.84% 27.06%
Net Nonoperating Expense Percent (NNEP)
-5.92% -7.33% -9.76% -3.27% 19.57% 6.57% 7.07% 6.28% 5.51% 4.12% 3.92%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 13.68%
Cost of Revenue to Revenue
19.70% 20.19% 19.72% 20.47% 13.02% 13.11% 13.16% 14.57% 17.62% 19.48% 21.52%
SG&A Expenses to Revenue
2.82% 3.12% 3.10% 3.26% 3.20% 3.02% 3.10% 3.10% 3.16% 2.92% 2.79%
R&D to Revenue
14.45% 15.62% 16.28% 15.45% 15.25% 15.53% 16.12% 17.01% 17.26% 16.83% 17.18%
Operating Expenses to Revenue
44.01% 45.79% 46.11% 45.85% 52.72% 51.32% 49.26% 59.68% 56.17% 51.53% 47.68%
Earnings before Interest and Taxes (EBIT)
13,977 12,909 13,478 14,449 14,350 14,058 15,495 10,404 12,631 15,255 17,738
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
16,838 15,418 15,929 17,234 17,269 17,026 18,411 13,526 18,739 21,394 23,912
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.37 3.09 3.09 3.72 7.30 13.15 41.26 0.00 262.05 36.90 22.70
Price to Tangible Book Value (P/TBV)
20.07 18.86 53.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.29 3.95 4.40 4.38 4.03 4.06 5.34 4.37 5.63 6.06 8.09
Price to Earnings (P/E)
16.50 16.44 17.60 48.12 14.35 15.67 15.72 27.60 33.07 30.69 37.30
Dividend Yield
1.36% 1.70% 1.58% 1.80% 1.74% 1.91% 1.39% 1.84% 1.31% 1.37% 1.03%
Earnings Yield
6.06% 6.08% 5.68% 2.08% 6.97% 6.38% 6.36% 3.62% 3.02% 3.26% 2.68%
Enterprise Value to Invested Capital (EV/IC)
4.14 3.79 3.44 4.14 4.37 4.56 5.83 4.98 4.42 4.66 5.34
Enterprise Value to Revenue (EV/Rev)
3.98 3.63 4.20 4.23 4.51 4.81 6.29 5.65 7.25 7.51 9.51
Enterprise Value to EBITDA (EV/EBITDA)
9.03 8.73 9.96 9.66 10.31 11.04 13.82 17.73 19.32 18.60 22.84
Enterprise Value to EBIT (EV/EBIT)
10.88 10.42 11.77 11.52 12.41 13.37 16.43 23.05 28.66 26.09 30.79
Enterprise Value to NOPAT (EV/NOPAT)
14.15 13.72 15.18 43.47 14.56 16.10 15.82 24.99 29.67 29.07 35.15
Enterprise Value to Operating Cash Flow (EV/OCF)
10.43 9.83 11.23 10.82 12.23 14.31 16.02 25.14 21.09 21.31 26.23
Enterprise Value to Free Cash Flow (EV/FCFF)
22.43 12.26 0.00 17.21 15.14 16.90 18.58 47.49 0.00 39.44 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.85 0.92 1.07 1.29 2.51 5.63 14.15 -13.15 58.15 9.40 4.41
Long-Term Debt to Equity
0.81 0.84 0.89 1.20 2.31 5.44 12.77 -12.50 55.54 8.25 4.07
Financial Leverage
-0.28 -0.25 -0.20 -0.15 0.17 1.34 3.55 498.09 -31.87 14.50 5.22
Leverage Ratio
2.08 2.30 2.42 2.70 3.56 6.39 13.21 1,306.54 -57.85 25.51 10.24
Compound Leverage Factor
1.91 2.04 2.10 2.32 3.04 5.48 11.08 960.57 -41.80 19.63 8.17
Debt to Total Capital
46.08% 47.85% 51.63% 56.39% 71.52% 84.92% 93.40% 108.23% 98.31% 90.39% 81.53%
Short-Term Debt to Total Capital
2.20% 4.09% 8.74% 4.18% 5.72% 2.81% 9.15% 5.35% 4.41% 11.03% 6.40%
Long-Term Debt to Total Capital
43.88% 43.76% 42.90% 52.22% 65.80% 82.11% 84.25% 102.88% 93.90% 79.35% 75.13%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.48% 0.55% 0.34% 0.47% 0.74% 0.76% 0.79% 0.64% 0.52% 0.56% 0.46%
Common Equity to Total Capital
53.44% 51.60% 48.02% 43.14% 27.74% 14.32% 5.81% -8.87% 1.17% 9.06% 18.01%
Debt to EBITDA
2.49 2.84 3.64 3.52 3.25 4.21 4.58 5.61 4.83 4.06 3.87
Net Debt to EBITDA
-0.74 -0.80 -0.51 -0.39 1.06 1.68 2.05 3.99 4.28 3.56 3.40
Long-Term Debt to EBITDA
2.37 2.60 3.02 3.26 2.99 4.07 4.13 5.33 4.61 3.56 3.57
Debt to NOPAT
3.91 4.47 5.54 15.83 4.59 6.13 5.24 7.91 7.42 6.35 5.96
Net Debt to NOPAT
-1.16 -1.25 -0.78 -1.73 1.50 2.44 2.34 5.62 6.58 5.57 5.24
Long-Term Debt to NOPAT
3.72 4.09 4.60 14.66 4.23 5.93 4.72 7.52 7.08 5.57 5.49
Altman Z-Score
3.20 2.88 2.58 2.46 2.17 1.88 1.81 1.40 1.65 1.89 2.39
Noncontrolling Interest Sharing Ratio
1.04% 0.97% 0.87% 0.88% 1.56% 3.48% 7.27% 633.70% -22.20% 9.43% 3.49%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.11 3.74 3.08 3.98 2.49 3.03 2.30 1.62 0.91 0.72 0.75
Quick Ratio
3.94 3.57 2.95 3.79 2.31 2.83 2.15 1.43 0.74 0.59 0.61
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
6,778 10,973 -107 9,676 11,756 11,121 13,701 5,049 -21,462 10,090 -1,353
Operating Cash Flow to CapEx
1,048.17% 1,150.97% 698.96% 886.29% 876.57% 840.09% 744.12% 211.46% 197.41% 271.96% 98.14%
Free Cash Flow to Firm to Interest Expense
5.93 7.48 -0.06 4.78 5.65 5.57 5.49 1.83 -6.12 2.87 -0.38
Operating Cash Flow to Interest Expense
12.76 9.33 7.86 7.60 6.99 6.59 6.37 3.46 4.90 5.31 5.82
Operating Cash Flow Less CapEx to Interest Expense
11.54 8.52 6.73 6.74 6.19 5.80 5.51 1.83 2.42 3.36 -0.11
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.38 0.33 0.31 0.29 0.32 0.35 0.33 0.35 0.41 0.38 0.37
Accounts Receivable Turnover
6.53 6.73 7.07 7.55 7.69 7.31 7.39 7.47 7.76 7.16 6.99
Inventory Turnover
29.95 28.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
11.33 9.64 8.11 7.03 6.50 6.25 6.09 5.06 3.73 2.74 1.76
Accounts Payable Turnover
11.80 11.42 13.51 14.29 9.27 8.42 7.71 6.00 6.98 5.80 3.31
Days Sales Outstanding (DSO)
55.88 54.20 51.60 48.36 47.44 49.91 49.41 48.86 47.01 50.96 52.25
Days Inventory Outstanding (DIO)
12.19 12.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
30.94 31.97 27.01 25.54 39.36 43.36 47.36 60.84 52.26 62.99 110.38
Cash Conversion Cycle (CCC)
37.13 35.07 24.59 22.82 8.08 6.55 2.05 -11.98 -5.25 -12.02 -58.13
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
36,688 35,520 46,077 40,231 40,703 41,257 43,643 48,189 81,850 85,447 102,334
Invested Capital Turnover
1.10 1.03 0.93 0.91 0.98 0.95 0.95 0.92 0.77 0.63 0.61
Increase / (Decrease) in Invested Capital
3,963 -1,168 10,557 -5,846 472 554 2,386 4,546 33,661 3,597 16,887
Enterprise Value (EV)
152,025 134,539 158,613 166,476 178,012 187,962 254,523 239,781 361,955 397,934 546,068
Market Capitalization
164,000 146,308 166,396 172,617 159,094 158,779 216,118 185,372 281,178 321,191 464,185
Book Value per Share
$11.14 $11.40 $13.09 $11.36 $6.37 $3.83 $1.82 ($2.33) $0.40 $3.17 $7.29
Tangible Book Value per Share
$1.87 $1.87 $0.76 ($0.99) ($7.98) ($11.24) ($14.26) ($19.29) ($26.31) ($21.98) ($16.53)
Total Capital
91,056 91,645 112,155 107,492 78,530 84,314 90,197 70,091 92,037 96,108 113,537
Total Debt
41,958 43,855 57,909 60,619 56,167 71,597 84,245 75,859 90,481 86,869 92,568
Total Long-Term Debt
39,959 40,105 48,112 56,128 51,673 69,226 75,995 72,110 86,420 76,264 85,297
Net Debt
-12,410 -12,270 -8,169 -6,642 18,340 28,540 37,691 53,957 80,294 76,208 81,365
Capital Expenditures (CapEx)
1,391 1,189 2,021 1,736 1,660 1,564 2,135 4,511 8,695 6,866 21,215
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5,055 -5,270 -5,944 -5,735 -5,577 -5,746 -6,901 -6,031 -8,212 -9,046 -11,996
Debt-free Net Working Capital (DFNWC)
49,313 50,855 60,134 61,526 32,250 37,311 39,653 15,871 1,975 1,615 -793
Net Working Capital (NWC)
47,314 47,105 50,337 57,035 27,756 34,940 31,403 12,122 -2,086 -8,990 -8,064
Net Nonoperating Expense (NNE)
803 904 998 243 1,145 1,540 2,341 2,878 3,696 3,220 3,091
Net Nonoperating Obligations (NNO)
-12,410 -12,270 -8,169 -6,642 18,340 28,540 37,691 53,957 80,294 76,208 81,365
Total Depreciation and Amortization (D&A)
2,861 2,509 2,451 2,785 2,919 2,968 2,916 3,122 6,108 6,139 6,174
Debt-free, Cash-free Net Working Capital to Revenue
-13.22% -14.23% -15.73% -14.56% -14.12% -14.71% -17.05% -14.21% -16.44% -17.08% -20.90%
Debt-free Net Working Capital to Revenue
129.00% 137.27% 159.12% 156.22% 81.63% 95.50% 97.96% 37.40% 3.95% 3.05% -1.38%
Net Working Capital to Revenue
123.77% 127.15% 133.19% 144.82% 70.26% 89.43% 77.58% 28.56% -4.18% -16.97% -14.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.26 $2.11 $2.27 $0.93 $3.05 $3.16 $4.67 $2.49 $3.15 $3.82 $4.46
Adjusted Weighted Average Basic Shares Outstanding
4.40B 4.22B 4.12B 4.12B 3.63B 3.21B 2.95B 2.70B 2.70B 2.74B 2.79B
Adjusted Diluted Earnings per Share
$2.21 $2.07 $2.21 $0.90 $2.97 $3.08 $4.55 $2.41 $3.07 $3.71 $4.34
Adjusted Weighted Average Diluted Shares Outstanding
4.50B 4.31B 4.22B 4.24B 3.73B 3.29B 3.02B 2.79B 2.77B 2.82B 2.87B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $3.16 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
4.34B 4.12B 4.14B 3.98B 3.34B 3.07B 2.79B 2.66B 2.71B 2.76B 2.81B
Normalized Net Operating Profit after Tax (NOPAT)
11,065 10,194 10,908 9,733 12,668 11,932 11,047 13,901 12,833 14,327 15,863
Normalized NOPAT Margin
28.95% 27.52% 28.86% 24.71% 32.06% 30.54% 27.29% 32.75% 25.69% 27.05% 27.64%
Pre Tax Income Margin
33.57% 30.89% 30.91% 31.55% 31.05% 30.88% 32.11% 18.02% 18.27% 22.17% 24.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
12.23 8.80 7.50 7.14 6.89 7.05 6.21 3.78 3.60 4.34 4.96
NOPAT to Interest Expense
9.40 6.68 5.81 1.89 5.87 5.85 6.45 3.48 3.48 3.90 4.34
EBIT Less CapEx to Interest Expense
11.01 7.99 6.37 6.28 6.10 6.26 5.35 2.14 1.12 2.39 -0.97
NOPAT Less CapEx to Interest Expense
8.18 5.87 4.69 1.03 5.08 5.07 5.59 1.85 1.00 1.94 -1.59
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
24.66% 29.50% 27.84% 87.54% 26.45% 30.29% 22.28% 51.47% 43.14% 41.95% 38.12%
Augmented Payout Ratio
106.04% 146.79% 65.51% 403.88% 352.54% 220.13% 174.57% 293.36% 58.43% 53.43% 42.94%

Quarterly Metrics And Ratios for Oracle

This table displays calculated financial ratios and metrics derived from Oracle's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 11/30/2022 2/28/2023 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
18.48% 17.93% 16.87% 8.81% 5.43% 7.11% 3.26% 6.86% 8.64% 6.40% 11.31%
EBITDA Growth
7,855.17% 9.39% 9.48% 20.80% 14.74% 13.11% 10.00% 15.18% 11.51% 11.19% 9.88%
EBIT Growth
467.20% -10.86% -6.15% 32.91% 20.27% 19.67% 14.70% 23.53% 17.96% 16.01% 10.13%
NOPAT Growth
532.34% -10.71% 11.60% 36.97% 33.66% 12.77% -11.86% 9.83% 17.68% 18.08% 8.25%
Net Income Growth
239.62% -18.24% 4.08% 56.33% 43.77% 26.64% -5.27% 21.03% 25.89% 22.28% 9.04%
EPS Growth
236.96% -19.05% 2.56% 53.57% 41.27% 25.00% -7.50% 19.77% 23.60% 20.00% 7.21%
Operating Cash Flow Growth
123.06% 11.18% 41.71% 9.07% -83.16% 28.07% 7.69% 6.50% 811.89% 8.37% 1.25%
Free Cash Flow Firm Growth
-449.59% -4,984.31% -4,885.81% 95.25% 95.69% 100.05% 101.02% -3.68% -133.13% -52,895.12% -4,359.77%
Invested Capital Growth
73.71% 73.31% 69.85% 6.40% 5.87% 3.86% 4.39% 6.49% 8.37% 13.60% 19.76%
Revenue Q/Q Growth
7.25% 1.00% 11.60% -10.00% 3.92% 2.62% 7.58% -6.86% 5.65% 0.51% 12.55%
EBITDA Q/Q Growth
15.07% 4.14% 20.58% -16.40% 9.30% 2.65% 17.27% -12.46% 5.81% 2.36% 15.89%
EBIT Q/Q Growth
22.80% 4.20% 29.94% -20.06% 11.12% 3.69% 24.54% -13.91% 6.11% 1.97% 18.23%
NOPAT Q/Q Growth
1.71% 11.75% 58.56% -23.99% -0.76% -5.71% 23.92% -5.28% 6.34% -5.39% 13.61%
Net Income Q/Q Growth
12.47% 8.90% 75.00% -27.06% 3.43% -4.08% 30.90% -6.81% 7.58% -6.82% 16.72%
EPS Q/Q Growth
12.50% 7.94% 76.47% -28.33% 3.49% -4.49% 30.59% -7.21% 6.80% -7.27% 16.67%
Operating Cash Flow Q/Q Growth
-86.72% 403.53% 32.09% 23.50% -97.95% 3,728.67% 11.07% 22.13% -82.44% 354.98% 3.78%
Free Cash Flow Firm Q/Q Growth
-3.93% -0.53% 7.26% 95.10% 5.70% 101.09% 1,927.66% -599.31% -112.05% -145.91% -63.60%
Invested Capital Q/Q Growth
6.52% 1.68% 0.89% -2.63% 6.00% -0.26% 1.41% -0.67% 7.87% 4.55% 6.92%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
82.26% 82.06% 82.52% 80.74% 80.78% 79.90% 80.65% 79.27% 79.24% 78.21% 77.39%
EBITDA Margin
36.64% 37.78% 40.82% 37.92% 39.88% 39.89% 43.49% 40.87% 40.93% 41.69% 42.93%
Operating Margin
25.02% 26.29% 29.91% 26.47% 27.99% 28.24% 32.79% 29.99% 30.02% 30.84% 32.13%
EBIT Margin
24.44% 25.21% 29.36% 26.07% 27.88% 28.17% 32.61% 30.14% 30.27% 30.71% 32.26%
Profit (Net Income) Margin
14.18% 15.29% 23.98% 19.43% 19.34% 18.08% 22.00% 22.01% 22.41% 20.78% 21.55%
Tax Burden Percent
81.20% 85.48% 106.76% 101.89% 92.02% 83.80% 83.13% 92.43% 92.95% 85.15% 82.52%
Interest Burden Percent
71.47% 70.95% 76.51% 73.14% 75.39% 76.58% 81.15% 79.01% 79.65% 79.45% 80.94%
Effective Tax Rate
18.80% 14.52% -6.76% -1.89% 7.98% 16.20% 16.87% 7.57% 7.05% 14.85% 17.48%
Return on Invested Capital (ROIC)
14.89% 16.85% 24.54% 17.78% 16.19% 15.03% 17.26% 18.13% 17.41% 16.28% 16.21%
ROIC Less NNEP Spread (ROIC-NNEP)
13.81% 15.56% 22.90% 16.59% 15.18% 14.11% 16.30% 17.12% 16.43% 15.29% 15.21%
Return on Net Nonoperating Assets (RNNOA)
-143.03% -212.22% -729.79% -999.80% 4,125.70% 532.26% 236.29% 182.55% 138.97% 102.09% 79.31%
Return on Equity (ROE)
-128.14% -195.37% -705.25% -982.02% 4,141.89% 547.29% 253.54% 200.68% 156.39% 118.37% 95.52%
Cash Return on Invested Capital (CROIC)
-34.75% -35.38% -33.01% 10.76% 11.25% 13.43% 12.06% 10.79% 8.61% 4.18% -1.44%
Operating Return on Assets (OROA)
9.57% 10.07% 12.04% 9.95% 10.95% 11.01% 12.54% 11.55% 11.76% 11.48% 11.97%
Return on Assets (ROA)
5.55% 6.10% 9.83% 7.42% 7.60% 7.07% 8.46% 8.43% 8.71% 7.77% 8.00%
Return on Common Equity (ROCE)
-136.85% -214.55% -861.81% -1,319.77% -2,614.48% 410.40% 229.63% 187.54% 147.97% 112.87% 92.19%
Return on Equity Simple (ROE_SIMPLE)
-207.16% -345.85% 0.00% 395.57% 262.21% 189.26% 0.00% 101.48% 84.56% 72.68% 0.00%
Net Operating Profit after Tax (NOPAT)
2,494 2,787 4,419 3,358 3,333 3,143 3,894 3,689 3,922 3,711 4,216
NOPAT Margin
20.32% 22.48% 31.94% 26.97% 25.76% 23.66% 27.26% 27.72% 27.90% 26.26% 26.51%
Net Nonoperating Expense Percent (NNEP)
1.08% 1.29% 1.64% 1.19% 1.01% 0.92% 0.96% 1.01% 0.98% 0.99% 1.00%
Return On Investment Capital (ROIC_SIMPLE)
- - - - 3.58% - - - 3.81% 3.27% 3.71%
Cost of Revenue to Revenue
17.74% 17.94% 17.48% 19.26% 19.22% 20.10% 19.35% 20.73% 20.76% 21.79% 22.61%
SG&A Expenses to Revenue
2.98% 3.24% 2.89% 3.16% 2.90% 2.84% 2.82% 2.69% 2.75% 2.76% 2.94%
R&D to Revenue
17.58% 17.31% 16.09% 17.79% 17.20% 16.93% 15.57% 17.33% 17.58% 17.19% 16.69%
Operating Expenses to Revenue
57.25% 55.77% 52.61% 54.28% 52.79% 51.66% 47.86% 49.27% 49.23% 47.37% 45.27%
Earnings before Interest and Taxes (EBIT)
3,000 3,126 4,062 3,247 3,608 3,741 4,659 4,011 4,256 4,340 5,131
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4,498 4,684 5,648 4,722 5,161 5,298 6,213 5,439 5,755 5,891 6,827
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 262.05 136.02 81.36 54.27 36.90 36.00 37.26 27.76 22.70
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
4.74 4.81 5.63 6.33 6.09 5.81 6.06 7.24 9.32 8.33 8.09
Price to Earnings (P/E)
24.82 27.55 33.07 34.39 31.03 28.67 30.69 35.48 44.06 38.20 37.30
Dividend Yield
1.58% 1.50% 1.31% 1.21% 1.32% 1.44% 1.37% 1.13% 0.87% 0.96% 1.03%
Earnings Yield
4.03% 3.63% 3.02% 2.91% 3.22% 3.49% 3.26% 2.82% 2.27% 2.62% 2.68%
Enterprise Value to Invested Capital (EV/IC)
3.79 3.87 4.42 5.02 4.68 4.55 4.66 5.46 6.44 5.68 5.34
Enterprise Value to Revenue (EV/Rev)
6.56 6.55 7.25 7.84 7.65 7.31 7.51 8.61 10.74 9.74 9.51
Enterprise Value to EBITDA (EV/EBITDA)
16.94 17.22 19.32 20.44 19.55 18.43 18.60 20.96 25.99 23.33 22.84
Enterprise Value to EBIT (EV/EBIT)
22.77 24.37 28.66 29.75 28.14 26.18 26.09 28.93 35.40 31.48 30.79
Enterprise Value to NOPAT (EV/NOPAT)
25.17 26.90 29.67 30.49 28.37 26.96 29.07 32.98 40.26 35.72 35.15
Enterprise Value to Operating Cash Flow (EV/OCF)
20.06 20.27 21.09 22.52 23.19 21.04 21.31 24.23 29.08 26.20 26.23
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 48.05 42.75 34.55 39.44 52.20 77.82 144.55 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-24.08 -48.02 58.15 31.31 20.28 14.23 9.40 7.50 6.23 5.58 4.41
Long-Term Debt to Equity
-21.50 -45.19 55.54 29.72 18.84 13.34 8.25 6.68 5.65 5.10 4.07
Financial Leverage
-10.36 -13.64 -31.87 -60.28 271.87 37.73 14.50 10.66 8.46 6.68 5.22
Leverage Ratio
-17.52 -23.73 -57.85 -102.37 436.53 62.93 25.51 19.91 15.19 12.73 10.24
Compound Leverage Factor
-12.52 -16.84 -44.27 -74.88 329.09 48.19 20.70 15.73 12.10 10.11 8.29
Debt to Total Capital
104.33% 102.13% 98.31% 96.90% 95.30% 93.43% 90.39% 88.24% 86.16% 84.80% 81.53%
Short-Term Debt to Total Capital
11.18% 6.02% 4.41% 4.90% 6.78% 5.85% 11.03% 9.61% 7.94% 7.19% 6.40%
Long-Term Debt to Total Capital
93.15% 96.10% 93.90% 92.00% 88.52% 87.58% 79.35% 78.63% 78.22% 77.60% 75.13%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.54% 0.57% 0.52% 0.51% 0.55% 0.59% 0.56% 0.47% 0.48% 0.47% 0.46%
Common Equity to Total Capital
-4.87% -2.69% 1.17% 2.58% 4.15% 5.97% 9.06% 11.29% 13.36% 14.74% 18.01%
Debt to EBITDA
5.09 5.03 4.83 4.55 4.39 4.22 4.06 3.82 3.90 4.13 3.87
Net Debt to EBITDA
4.68 4.55 4.28 3.93 3.96 3.75 3.56 3.33 3.41 3.37 3.40
Long-Term Debt to EBITDA
4.55 4.73 4.61 4.32 4.08 3.96 3.56 3.41 3.54 3.78 3.57
Debt to NOPAT
7.57 7.86 7.42 6.78 6.38 6.18 6.35 6.01 6.05 6.33 5.96
Net Debt to NOPAT
6.96 7.11 6.58 5.86 5.75 5.48 5.57 5.24 5.28 5.16 5.24
Long-Term Debt to NOPAT
6.76 7.39 7.08 6.44 5.92 5.79 5.57 5.36 5.49 5.79 5.49
Altman Z-Score
1.00 1.13 1.44 1.60 1.61 1.59 1.65 1.94 2.53 2.22 2.14
Noncontrolling Interest Sharing Ratio
-6.80% -9.82% -22.20% -34.39% 163.12% 25.01% 9.43% 6.55% 5.38% 4.65% 3.49%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.65 0.82 0.91 0.87 0.79 0.85 0.72 0.72 0.81 1.02 0.75
Quick Ratio
0.50 0.65 0.74 0.73 0.63 0.69 0.59 0.59 0.67 0.87 0.61
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-31,364 -31,530 -29,242 -1,433 -1,351 15 297 -1,485 -3,150 -7,745 -12,671
Operating Cash Flow to CapEx
34.87% 162.67% 295.19% 530.75% 13.24% 327.06% 217.33% 322.49% 32.85% 101.21% 67.81%
Free Cash Flow to Firm to Interest Expense
-36.64 -34.73 -30.65 -1.64 -1.52 0.02 0.34 -1.76 -3.64 -8.68 -12.96
Operating Cash Flow to Interest Expense
0.99 4.71 5.92 8.00 0.16 6.25 6.93 8.82 1.51 6.65 6.30
Operating Cash Flow Less CapEx to Interest Expense
-1.85 1.81 3.91 6.49 -1.06 4.34 3.74 6.09 -3.08 0.08 -2.99
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.39 0.40 0.41 0.38 0.39 0.39 0.38 0.38 0.39 0.37 0.37
Accounts Receivable Turnover
8.64 8.88 7.76 8.18 7.94 7.77 7.16 7.40 7.33 7.27 6.99
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
4.12 3.84 3.73 3.41 3.19 2.96 2.74 2.64 2.47 2.18 1.76
Accounts Payable Turnover
5.52 5.91 6.98 7.39 6.92 6.10 5.80 6.59 5.87 5.65 3.31
Days Sales Outstanding (DSO)
42.22 41.10 47.01 44.61 45.96 46.95 50.96 49.31 49.77 50.21 52.25
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
66.13 61.80 52.26 49.40 52.76 59.81 62.99 55.39 62.19 64.65 110.38
Cash Conversion Cycle (CCC)
-23.91 -20.69 -5.25 -4.80 -6.80 -12.85 -12.02 -6.08 -12.42 -14.44 -58.13
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
79,793 81,130 81,850 79,699 84,477 84,258 85,447 84,873 91,549 95,714 102,334
Invested Capital Turnover
0.73 0.75 0.77 0.66 0.63 0.64 0.63 0.65 0.62 0.62 0.61
Increase / (Decrease) in Invested Capital
33,858 34,317 33,661 4,791 4,684 3,128 3,597 5,174 7,072 11,456 16,887
Enterprise Value (EV)
302,336 314,250 361,955 399,697 395,159 383,785 397,934 463,432 589,989 543,447 546,068
Market Capitalization
218,297 230,699 281,178 322,368 314,548 305,150 321,191 389,375 512,186 464,463 464,185
Book Value per Share
($1.58) ($0.90) $0.40 $0.87 $1.41 $2.05 $3.17 $3.92 $4.96 $5.98 $7.29
Tangible Book Value per Share
($28.70) ($27.68) ($26.31) ($25.39) ($24.36) ($23.36) ($21.98) ($20.94) ($19.54) ($18.08) ($16.53)
Total Capital
87,143 89,899 92,037 91,782 93,167 94,162 96,108 95,784 102,860 113,537 113,537
Total Debt
90,919 91,811 90,481 88,941 88,789 87,980 86,869 84,515 88,624 96,276 92,568
Total Long-Term Debt
81,173 86,396 86,420 84,442 82,468 82,470 76,264 75,314 80,462 88,109 85,297
Net Debt
83,569 83,042 80,294 76,858 80,099 78,076 76,208 73,604 77,313 78,453 81,365
Capital Expenditures (CapEx)
2,435 2,628 1,913 1,314 1,080 1,674 2,798 2,303 3,970 5,862 9,080
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-7,149 -7,538 -8,212 -10,775 -7,487 -8,216 -9,046 -10,683 -8,698 -9,163 -11,996
Debt-free Net Working Capital (DFNWC)
201 1,231 1,975 1,308 1,203 1,688 1,615 228 2,613 8,660 -793
Net Working Capital (NWC)
-9,545 -4,184 -2,086 -3,191 -5,118 -3,822 -8,990 -8,973 -5,549 493 -8,064
Net Nonoperating Expense (NNE)
753 891 1,101 938 830 742 751 760 771 775 789
Net Nonoperating Obligations (NNO)
83,569 83,042 80,294 76,858 80,099 78,076 76,208 73,604 77,313 78,453 81,365
Total Depreciation and Amortization (D&A)
1,498 1,558 1,586 1,475 1,553 1,557 1,554 1,428 1,499 1,551 1,696
Debt-free, Cash-free Net Working Capital to Revenue
-15.52% -15.72% -16.44% -21.14% -14.50% -15.65% -17.08% -19.85% -15.83% -16.43% -20.90%
Debt-free Net Working Capital to Revenue
0.44% 2.57% 3.95% 2.57% 2.33% 3.21% 3.05% 0.42% 4.76% 15.52% -1.38%
Net Working Capital to Revenue
-20.72% -8.72% -4.18% -6.26% -9.91% -7.28% -16.97% -16.67% -10.10% 0.88% -14.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.65 $0.70 $1.22 $0.89 $0.91 $0.87 $1.15 $1.06 $1.13 $1.05 $1.22
Adjusted Weighted Average Basic Shares Outstanding
2.70B 2.70B 2.70B 2.73B 2.75B 2.75B 2.74B 2.76B 2.79B 2.80B 2.79B
Adjusted Diluted Earnings per Share
$0.63 $0.68 $1.20 $0.86 $0.89 $0.85 $1.11 $1.03 $1.10 $1.02 $1.19
Adjusted Weighted Average Diluted Shares Outstanding
2.75B 2.78B 2.77B 2.82B 2.82B 2.82B 2.82B 2.85B 2.87B 2.87B 2.87B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.70B 2.70B 2.71B 2.74B 2.75B 2.75B 2.76B 2.77B 2.80B 2.80B 2.81B
Normalized Net Operating Profit after Tax (NOPAT)
2,655 2,885 3,024 2,412 3,453 3,348 4,056 3,768 4,029 3,788 4,284
Normalized NOPAT Margin
21.63% 23.27% 21.86% 19.36% 26.68% 25.21% 28.39% 28.32% 28.66% 26.81% 26.94%
Pre Tax Income Margin
17.47% 17.89% 22.46% 19.07% 21.02% 21.57% 26.46% 23.81% 24.11% 24.40% 26.11%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.50 3.44 4.26 3.72 4.06 4.27 5.31 4.76 4.91 4.87 5.25
NOPAT to Interest Expense
2.91 3.07 4.63 3.85 3.75 3.59 4.44 4.38 4.53 4.16 4.31
EBIT Less CapEx to Interest Expense
0.66 0.55 2.25 2.22 2.85 2.36 2.12 2.03 0.33 -1.71 -4.04
NOPAT Less CapEx to Interest Expense
0.07 0.17 2.63 2.34 2.54 1.68 1.25 1.65 -0.05 -2.41 -4.97
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
39.02% 41.08% 43.14% 41.59% 40.79% 41.07% 41.95% 40.11% 38.04% 36.53% 38.12%
Augmented Payout Ratio
64.56% 61.91% 58.43% 51.17% 49.67% 52.35% 53.43% 51.07% 45.80% 41.48% 42.94%

Key Financial Trends

Oracle (NYSE: ORCL) has demonstrated solid financial performance and resilience over the past four years, highlighted by growing revenues, expanding operating income, and consistent profitability. Here are the key takeaways from their recent financial statements through Q4 2025, along with notable trends since early 2021.

  • Revenue Growth: Oracle’s operating revenue increased from approximately $9.7 billion in Q1 2022 to $15.9 billion in Q4 2025, showing a substantial upward trend and reflecting successful business expansion.
  • Strong Gross Profit Margins: Gross profit remained robust, growing from around $8.3 billion in Q1 2022 to approximately $12.3 billion in latest quarter, indicating efficient cost management relative to revenue.
  • Consistent Net Income Growth: Net income rose steadily, from about $2.5 billion in Q1 2022 to $3.4 billion by Q4 2025, reflecting improving profitability.
  • Operating Income Expansion: Operating income climbed from roughly $3.4 billion in Q1 2022 to over $5.1 billion in Q4 2025, indicating enhanced core business performance.
  • Cash Flow from Operations: Operating cash flow showed strength, with $6.2 billion generated in Q4 2025, supporting sustainable operating activities.
  • Increasing Capital Expenditures: Significant investments into property, plant, and equipment were noted, with capital expenditures reaching $9 billion in Q4 2025, indicating aggressive asset growth but also higher cash outflows.
  • Debt Management: Oracle's long-term debt increased moderately, reaching approximately $88 billion by Q3 2025. The company actively repaid and issued debt, balancing financing needs.
  • Share Repurchases and Dividends: Oracle continues to return capital via share repurchases (around $150 million quarterly) and steady dividends (about $0.40 per common share), signaling commitment to shareholder returns.
  • Rising Operating Expenses: Total operating expenses increased alongside revenue, particularly marketing and research & development costs, which could pressure margins if growth slows.
  • Equity Fluctuations and Negative Retained Earnings: Despite net income growth, retained earnings remain negative in recent years, and total common equity is relatively low compared to liabilities, reflecting accumulated deficits or accounting adjustments that investors should monitor.

Summary: Oracle’s financials illustrate a strong growth trajectory in revenue and profitability with solid cash generation, supported by ongoing investments in assets and technology. The company prudently manages its capital structure with balanced debt issuance and repayments, while rewarding shareholders through dividends and modest buybacks. However, rising costs and equity position warrant keeping an eye as they could impact future financial flexibility.

Retail investors considering Oracle should focus on its ability to sustain growth and manage expenses while monitoring capital allocation strategies and equity strength going forward.

08/24/25 08:56 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Oracle's Financials

When does Oracle's fiscal year end?

According to the most recent income statement we have on file, Oracle's financial year ends in May. Their financial year 2025 ended on May 31, 2025.

How has Oracle's net income changed over the last 10 years?

Oracle's net income appears to be on an upward trend, with a most recent value of $12.44 billion in 2025, rising from $9.94 billion in 2015. The previous period was $10.47 billion in 2024. View Oracle's forecast to see where analysts expect Oracle to go next.

What is Oracle's operating income?
Oracle's total operating income in 2025 was $17.68 billion, based on the following breakdown:
  • Total Gross Profit: $45.05 billion
  • Total Operating Expenses: $27.37 billion
How has Oracle's revenue changed over the last 10 years?

Over the last 10 years, Oracle's total revenue changed from $38.23 billion in 2015 to $57.40 billion in 2025, a change of 50.2%.

How much debt does Oracle have?

Oracle's total liabilities were at $147.39 billion at the end of 2025, a 11.9% increase from 2024, and a 138.5% increase since 2015.

How much cash does Oracle have?

In the past 10 years, Oracle's cash and equivalents has ranged from $9.77 billion in 2023 to $37.24 billion in 2020, and is currently $10.79 billion as of their latest financial filing in 2025.

How has Oracle's book value per share changed over the last 10 years?

Over the last 10 years, Oracle's book value per share changed from 11.14 in 2015 to 7.29 in 2025, a change of -34.6%.



This page (NYSE:ORCL) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners